Mednax Inc Stock
Mednax Inc Stock
Mednax Inc gained 1.110% today.
Our community is currently high on Mednax Inc with 3 Buy predictions and 0 Sell predictions.
However, we have a potential of -6.59% for Mednax Inc as the target price of 17 € is below the current price of 18.2 €.
For the coming years our community has positive and negative things to say abot the Mednax Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Mednax Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mednax Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mednax Inc | 1.110% | 2.857% | -7.216% | 36.364% | -2.174% | 28.571% | -21.739% |
| Select Medical Holdings | 0.740% | 5.385% | 6.202% | -22.599% | 9.600% | -51.071% | -38.839% |
| Chemed Corp. | 0.000% | 4.211% | 2.062% | -24.571% | 8.791% | - | - |
| Molina Healthcare | 1.570% | 8.582% | -30.648% | -56.546% | -21.575% | -58.813% | -35.674% |
Comments
Pediatrix Medical Group (NYSE:MD) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) was upgraded by analysts at Zacks Research to a "strong-buy" rating.
Show more
Ratings data for MD provided by MarketBeat
Pediatrix Medical Group, Inc. (NYSE: MD) had its price target raised by analysts at Macquarie from $19.00 to $20.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MD provided by MarketBeat